Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Virology|July 10, 2026
A single-dose chimeric Newcastle disease virus (NDV)/chikungunya virus (CHIKV) is an effective CHIKV vaccine candidateQiu-Yan Zhang, Yang Zhang, Zhe-Rui Zhang, et al.
Virologica Sinica|July 30, 2026
A replication-defective tick-borne encephalitis virus generated by NS1 trans-complementation confers robust protective efficacyJi Zhang, Qiu-Yan Zhang, Zhe-Rui Zhang, et al.
Emerging Microbes & Infections|January 17, 2022
A new screening system for entry inhibitors based on cell-to-cell transmitted syncytia formation mediated by self-propagating hybrid VEEV-SARS-CoV-2 repliconNa Li, Xiao-Ling Chen, Qi Li, et al.
Organic & Biomolecular Chemistry|November 10, 2025
Mechanism and origin of enantioselectivity for Diels-Alder reaction catalyzed by chiral phosphoric acids in synthesising 1-trifluoroacetamido cyclohex-1-eneYu-Hao Qiao, Xiao-Heng Wang, Dong Xie, et al.
The Journal of Infectious Diseases|June 27, 2023
A Chimeric Classical Insect-Specific Flavivirus Provides Complete Protection Against West Nile Virus Lethal Challenge in MiceHong-Qing Zhang, Na Li, Zhe-Rui Zhang, et al.
Journal of Virology|February 2, 2022
High-Titer Self-Propagating Capsidless Chikungunya Virus Generated in Vero Cells as a Strategy for Alphavirus Vaccine DevelopmentYa-Nan Zhang, Zhe-Rui Zhang, Na Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2024
Rational design of self-amplifying virus-like vesicles with Ebola virus glycoprotein as vaccinesHong-Qing Zhang, Ya-Nan Zhang, Cheng-Lin Deng, et al.
Virologica Sinica|August 10, 2021
In Vitro Inhibition of Alphaviruses by LycorineNa Li, Zhen Wang, Rui Wang, et al.
Materials (Basel, Switzerland)|December 9, 2023
Mechanism for Improved Curie Temperature and Magnetic Entropy Change in Sm-Doped Fe88Zr8B4 Amorphous AlloysZhe-Rui Zhang, Xiang-Jie Liu, He-Teng Zhang, et al.
NPJ Vaccines|August 18, 2020
A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in miceNa Li, Zhe-Rui Zhang, Ya-Nan Zhang, et al.
Pageof 3